Immunologix Laboratories published a blog exploring how integrated ADA, PK, and PD data can answer clinical questions about neutralizing antibody activity in biologic therapeutics, drawing on a perspective published in Bioanalysis by Dr. Devangi Mehta and colleagues at CSL.

Immunologix Laboratories is a unique scientific partner, offering GLP and GCP compliant laboratory capabilities focused on ligand binding-based bioanalysis coupled with expert scientific consultation from our Translational Sciences team. Our laboratory specializes in Immunogenicity, Neutralizing Antibody (cell-based and ligand binding based), PK, and Biomarker assays in support of preclinical and clinical studies. Translational Sciences provides dedicated scientific resources to advise, develop and implement scientific strategies and practical solutions for innovator development programs. Our fully customizable approach includes delivering stage-appropriate biomarker & bioanalytical strategies, assay development and validation, study data interpretation, and support for regulatory interactions and filings. Our exceptional scientific experts work together as an integrated team ensuring that our client’s projects receive full benefit of the breadth and depth of experience gained over many decades within both contract laboratory and drug development organizations. The integration of Translational Sciences with the laboratory is unique within our industry and this confluence of expertise enables our team to deliver valuable scientific insights that accelerate decision making and the course of drug development. Please contact us at info@immunologixlabs.com